Pharmapack Europe is an unmissable gathering of the pharmaceutical industry and healthcare product professionals, bringing together 260 exhibitors and over 2,800 key decision-makers from 54 countries on 15-16 February 2012 at the Grande Halle de la Villette, PARIS (FRANCE).
Recognised for the great quality of its visitors, its conferences and its exhibition, Pharmapack Europe has always kept itself up to date from one year to the next, in order to better respond to the new challenges of the healthcare industry. So, after 17 years of existence, the first European event dedicated to innovation in packaging and drug delivery systems continues to improve, grow in size, and expand internationally.
A programme focusing on innovation and new themes
Now in its 11th year, Pharmapack Europe is introducing several new features. The conference programme will cover an even wider range of themes, dealing with the issues connected to developing drug delivery systems, as well as primary, secondary and tertiary packaging.
Furthermore, innovation will be the guiding track during the two days, “in the sense of opening up new areas for consideration for those involved in the sector,” explains Aurore Domange, Event Manager for Pharmapack Europe. She continues, “in addition, we are going even further by offering a semi-scientific programme with presentations from experts in the industrial sector, healthcare organisations and authorities, as well as experts from research facilities and universities. The objective is to develop a fertile environment for innovation by facilitating meetings for stakeholders from different stages of the process, and even experts from fields outside the pharmaceutical spectrum.”
One distinguished expert is Patrice Noailles who will open the conference programme with a presentation on the theme, “From Mesopotamia to modern times, think different about innovation.”
Another important theme for the 2012 edition is “Sustainability: challenges and practices,” which will be approached through exchanges of experience and presentations of innovative solutions that enable the cost and environmental impact of packaging to be reduced, at the same time as optimising its functions (protecting the medicine and acting as a vehicle for regulatory information and correct use of the medicine).
Half a day will be dedicated to the theme “New materials, compatibility and drug delivery for injectables.” The participants will provide a full report on regulations and the latest innovations and developments in these areas, which are all the more crucial considering the strong growth in injectables at present.
The theme “Packaging design for better compliance, security and patient safety,” a key driver for innovation and a major concern among healthcare product manufacturers, will also be covered. Notably, this will feature an update on European regulations about child-resistant packaging and a brand new theme, “The behaviour of teenagers about packaging: how to induce compliance for this target?” Co-Chairperson of this session, Sébastien Fily, Packaging Development Specialist & Marketing, Galderma (Canada) comments, “we know that teenagers are rebels at heart. This makes them an interesting target to study with regard to their behaviour towards medicines. In addition, this is the age at which the adult person is formed, along with his or her habits in terms of consumption and use of products and treatments.”
Pharmapack Europe in Paris